See more : Tibet Huayu Mining Co., Ltd. (601020.SS) Income Statement Analysis – Financial Results
Complete financial analysis of Cian Healthcare Limited (CHCL.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Cian Healthcare Limited, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- Wärtsilä Oyj Abp (WRT1V.HE) Income Statement Analysis – Financial Results
- Craneware plc (CRW.L) Income Statement Analysis – Financial Results
- JSB Financial Inc. (JFWV) Income Statement Analysis – Financial Results
- Starrex International Ltd. (STXMF) Income Statement Analysis – Financial Results
- The Sailor Pen Co., Ltd. (7992.T) Income Statement Analysis – Financial Results
Cian Healthcare Limited (CHCL.BO)
About Cian Healthcare Limited
Cian Healthcare Ltd. engages in the development and manufacture of pharmaceuticals, cosmeceuticals, and nutraceutical products. It provides products for the orthopedics, gynecology, pediatrics, cardiac, diabetic, dermatology, pain management, antibiotics, neuro, critical care, gastro-intestinal, and nutraceuticals division. The firm's products include domestic products, contract manufacturing, export, government tender, and innovative products. Cian Healthcare was founded on January 7, 2003 and is headquartered in Pune, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 616.96M | 685.90M | 778.45M | 736.07M | 569.17M | 624.42M | 594.17M | 517.83M | 466.82M |
| Cost of Revenue | 503.79M | 552.46M | 716.62M | 602.02M | 482.20M | 528.89M | 452.05M | 408.87M | 383.57M |
| Gross Profit | 113.17M | 133.44M | 61.82M | 134.05M | 86.97M | 95.53M | 142.13M | 108.97M | 83.26M |
| Gross Profit Ratio | 18.34% | 19.45% | 7.94% | 18.21% | 15.28% | 15.30% | 23.92% | 21.04% | 17.83% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 55.61M | 57.34M | 45.94M | 57.20M | 33.69M | 30.63M | 27.29M | 26.37M |
| Selling & Marketing | 0.00 | 2.26M | 1.78M | 2.74M | 809.00K | 1.52M | 1.24M | 227.00K | 244.00K |
| SG&A | 59.20M | 57.87M | 59.12M | 48.68M | 58.01M | 35.21M | 31.87M | 27.52M | 26.61M |
| Other Expenses | 0.00 | -5.12M | -441.00K | -990.00K | -205.00K | -6.51M | -11.00K | -422.00K | -1.77M |
| Operating Expenses | 59.20M | 62.99M | 59.56M | 49.67M | 58.21M | 41.72M | 31.88M | 27.94M | 28.38M |
| Cost & Expenses | 562.99M | 615.45M | 776.18M | 651.69M | 540.42M | 570.61M | 483.92M | 436.80M | 411.95M |
| Interest Income | 0.00 | 1.40M | 1.61M | 1.93M | 1.82M | 53.86M | 0.00 | 0.00 | 0.00 |
| Interest Expense | 57.90M | 56.89M | 64.42M | 77.23M | 71.20M | 50.96M | 59.41M | 50.94M | 38.01M |
| Depreciation & Amortization | 64.15M | 70.27M | 68.57M | 58.93M | 51.69M | 29.23M | 19.45M | 19.47M | 19.30M |
| EBITDA | 122.57M | 147.07M | 72.95M | 143.03M | 87.65M | 89.60M | 131.46M | 101.20M | 78.91M |
| EBITDA Ratio | 19.87% | 20.52% | 9.10% | 19.47% | 14.13% | 13.30% | 21.83% | 19.41% | 15.89% |
| Operating Income | 53.97M | 70.45M | 2.27M | 84.38M | 28.76M | 53.81M | 110.25M | 81.03M | 54.88M |
| Operating Income Ratio | 8.75% | 10.27% | 0.29% | 11.46% | 5.05% | 8.62% | 18.55% | 15.65% | 11.76% |
| Total Other Income/Expenses | -53.45M | -50.54M | -62.30M | -77.51M | -64.00M | -44.40M | -59.42M | -50.24M | -33.27M |
| Income Before Tax | 522.00K | 19.91M | -60.03M | 6.87M | -35.24M | 9.41M | 52.60M | 30.79M | 21.60M |
| Income Before Tax Ratio | 0.08% | 2.90% | -7.71% | 0.93% | -6.19% | 1.51% | 8.85% | 5.95% | 4.63% |
| Income Tax Expense | -2.02M | -387.00K | -4.70M | 6.34M | 2.63M | 2.86M | 12.55M | 7.66M | 6.13M |
| Net Income | 2.54M | 20.30M | -55.34M | 531.00K | -37.88M | 6.55M | 40.05M | 23.13M | 15.47M |
| Net Income Ratio | 0.41% | 2.96% | -7.11% | 0.07% | -6.65% | 1.05% | 6.74% | 4.47% | 3.31% |
| EPS | 0.10 | 0.81 | -2.21 | 0.02 | -1.62 | 0.38 | 286.06 | 16.52 | 11.05 |
| EPS Diluted | 0.10 | 0.81 | -2.21 | 0.02 | -1.62 | 0.38 | 286.06 | 16.52 | 11.05 |
| Weighted Avg Shares Out | 25.00M | 25.00M | 25.00M | 23.36M | 23.36M | 17.15M | 140.00K | 1.40M | 1.40M |
| Weighted Avg Shares Out (Dil) | 25.00M | 25.00M | 25.00M | 23.36M | 23.36M | 17.15M | 140.00K | 1.40M | 1.40M |
Source: https://incomestatements.info
Category: Stock Reports